Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.M. Prince
Final Data From the Phase 3 Alcanza Study: Brentuximab Vedotin (Bv) vs Physician's Choice (Pc) in Patients (Pts) With Cd30-Positive (Cd30+) Cutaneous T-Cell Lymphoma (Ctcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Clinical Outcomes From Venetoclax Based Therapy in Patients With Relapsed/Refractory B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Response to Brentuximab Vedotin by Cd30 Expression: Results From Five Trials in Ptcl, Ctcl, and B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Targeted Drug Brentuximab Vedotin for Treatment of Relapsed or Refractory Cd30-Positive Hodgkin’s Lymphoma
Malignant tumours
Brentuximab Vedotin for Relapsed or Refractory CD30+ Hodgkin Lymphoma: A Multicenter Analysis From Asia
OncoTargets and Therapy
Oncology
Pharmacology
Oral Mycosis Fungoides With CD30+ Large Cell Transformation Successfully Treated With Brentuximab Vedotin
JAAD Case Reports
Dermatology
Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Primary Cutaneous CD30-positive Large T-Cell Lymphoma With Secondary Lymph Node Involvement Detected by Sentinel Lymphonodectomy
Acta Dermato-Venereologica
Dermatology
Medicine
Our First Experiences With Brentuximab Vedotin in the Treatment of Cutaneous T-Cell Lymphoma
Bőrgyógyászati és Venerológiai Szemle
CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Primary Cutaneous CD30+ Anaplastic Large T Cell Lymphoma. A Series of Nine Cases
Gaceta Medica de Mexico
Medicine
